Cardio Diagnostics Holdings (CDIO) Restructuring Costs (2022)

Cardio Diagnostics Holdings has disclosed Restructuring Costs across 1 years of filings, most recently posting $55034.0 for Q2 2022.

• In Q2 2022, Restructuring Costs changed N/A year-over-year to $55034.0; the TTM figure through Mar 2023 stood at $55034.0 (changed N/A YoY), while the FY2022 annual figure was $112534.0, changed N/A from the prior year.
• Restructuring Costs came in at $55034.0 for Q2 2022 at Cardio Diagnostics Holdings, down from $57500.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $57500.0 in Q1 2022 to a low of $55034.0 in Q2 2022.